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What causes measles? 
Measles is caused by a virus. 
How does measles spread? 
Measles is spread from person to person through 
the air by infectious droplets; it is highly contagious.
How long does it take to show signs of measles 
after being exposed? 
It takes an average of 10–12 days from exposure to 
the first symptom, which is usually fever. The measles 
rash doesn’t usually appear until approximately 14 
days after exposure, 2–3 days after the fever begins.
What are the symptoms of measles? 
Symptoms include fever, runny nose, cough, loss of 
appetite, “pink eye,” and a rash. The rash usually lasts 
5–6 days and begins at the hairline, moves to the 
face and upper neck, and proceeds down the body. 
How serious is measles? 
Measles can be a serious disease, with 30% of 
reported cases experiencing one or more complica-
tions. Death from measles occurs in 2 to 3 per 1,000 
reported cases in the United States. Complications 
from measles are more common among very young 
children (younger than five years) and adults (older 
than 20 years). 
What are possible complications from measles? 
Diarrhea is the most common complication of  
measles (occurring in 8% of cases), especially in 
young children. Ear infections occur in 7% of reported 
cases. Pneumonia, occurring in 6% of reported 
cases, accounts for 60% of measles-related deaths. 
Approximately one out of one thousand cases will 
develop acute encephalitis, an inflammation of the 
brain. This serious complication can lead to perma-
nent brain damage. 
Measles during pregnancy increases the risk of 
premature labor, miscarriage, and low-birth-weight 
infants, although birth defects have not been linked 
to measles exposure. 
Measles can be especially severe in persons with 
compromised immune systems. Measles is more 
severe in malnourished children, particularly those 
with vitamin A deficiency. In developing countries, 
the fatality rate may be as high as 25%.
How is measles diagnosed? 
Measles is diagnosed by a combination of the patient’s 
symptoms and by laboratory tests. 
Is there a treatment for measles? 
There is no specific treatment for measles. People 
with measles need bed rest, fluids, and control  
of fever. Patients with complications may need treat-
ment specific to their problem. 
How long is a person with measles contagious? 
Measles is highly contagious and can be transmitted 
from four days before the rash becomes visible to 
four days after the rash appears. 
What should be done if someone is exposed to 
measles? 
Notification of the exposure should be communicated 
to a doctor. If the person has not been vaccinated, 
measles vaccine may prevent disease if given within 
72 hours of exposure. Immune globulin (a blood 
product containing antibodies to the measles virus) 
may prevent or lessen the severity of measles if 
given within six days of exposure. 
How common is measles in the United States? 
Before the vaccine was licensed in 1963, there were 
an estimated 3–4 million cases each year. In the 
years following 1963, the number of measles cases 
dropped dramatically with only 1,497 cases in 1983, 
the lowest annual total reported up to that time.  
By 2004, only 37 cases were reported – a record low. 
However, new cases continued to be reported, pri-
marily in populations that have refused vaccination 
for religious or personal belief reasons. From 2001 
through 2011, an average of 63 measles cases (range, 
37 to 220) and four outbreaks were reported each 
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year in the United States. Of the 911 cases, a total  
of 372 (41%) were imported from outside the U.S. 
and an additional 432 (47%) were associated with 
importations. Hospitalization was reported for  
225 (25%) cases. Two deaths were reported. Most 
cases occur among people who declined vaccination 
because of a religious, or personal objection.
The U.S. experienced a record number of measles 
cases during 2014, with 644 cases reported from  
27 states. This is the greatest number of cases since 
measles elimination was documented in the U.S.  
in 2000. In 2015, the U.S. experienced a large, multi-
state outbreak of measles linked to an amusement 
park; for up-to-date case counts and outbreak infor-
mation, visit CDC’s Measles Cases and Outbreaks 
web page at  
www.cdc.gov/measles/cases-outbreaks.html.
Can someone get measles more than once? 
No.
When did vaccines for measles, mumps, and 
rubella become available? 
The first measles vaccines (an inactivated and a  
live virus product) became available in 1963, both  
of which were largely replaced by a further attenu-
ated live virus vaccine that was licensed in 1968.  
The mumps vaccine first became available in 1967,  
followed by the rubella vaccine in 1969. These  
three vaccines were combined in 1971 to form the 
measles-mumps-rubella (MMR) vaccine. A vaccine 
that combines both MMR and varicella (chickenpox) 
vaccines, known as MMRV, became available in 
2005. Single antigen measles, mumps, and rubella 
vaccines are no longer available in the U.S. 
What kind of vaccine is it? 
MMR vaccine contains live, attenuated (or weakened) 
strains of the measles, mumps, and rubella viruses. 
How is this vaccine given? 
This vaccine is a shot given subcutaneously (in the 
fatty layer of tissue under the skin). 
Who should get this vaccine? 
All children, adolescents, and adults born in 1957 
or later without a valid contraindication should have 
documentation of vaccination or other evidence  
of immunity. Additionally, some healthcare personnel 
who were born before 1957 may also need proof of 
vaccination or other evidence of immunity. 
What kind of “evidence of immunity” can 
substitute for MMR vaccination? 
Evidence of immunity can be shown by having labo-
ratory evidence of immunity to measles, mumps, 
and/or rubella or laboratory confirmation of disease. 
However, if a person doesn’t have evidence of immu-
nity to all three diseases (e.g., measles, mumps, and 
rubella), they would still need to get vaccinated with 
MMR since the vaccine is not available as a single 
antigen product in the U.S. 
At what age should the first dose of MMR be 
given? 
The first dose of MMR should be given on or after the 
child’s first birthday; the recommended age range is 
from 12–15 months. A dose given before 12 months 
of age will not be counted, so the child’s medical 
appointment should be scheduled with this in mind. 
When should children get the second MMR shot? 
The second dose is usually given when the child is 
4–6 years old, or before he or she enters kindergarten 
or first grade. However, the second dose can be 
given earlier as long as there has been an interval  
of at least 28 days since the first dose.
How effective is this vaccine? 
The first dose of MMR produces immunity to measles 
and rubella in 90% to 95% of recipients. The second 
dose of MMR is intended to produce immunity in 
those who did not respond to the first dose, but a 
very small percentage of people may not be protected 
even after a second dose. 
Which adolescents and adults should receive 
the MMR vaccine? 
All unvaccinated adolescents without a valid contra-
indication to the vaccine should have documentation 
of two doses of MMR. All adults born in or after 
1957 should also have documentation of vaccination 
or other evidence of immunity.
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Adults born before 1957 are likely to have had measles 
and/or mumps disease as a child and are generally 
(but not always) considered not to need vaccination. 
Which adults need two doses of MMR vaccine? 
Certain adults are at higher risk of exposure to mea-
sles, mumps, and/or rubella and may need a second 
dose of MMR unless they have other evidence of 
immunity; this includes adults who are: 
•  students in postsecondary educational institutions 
(for measles and mumps) 
•  healthcare personnel (for measles and mumps) 
•  living in a community experiencing an outbreak  
or recently exposed to the disease (for measles 
and mumps) 
•  planning to travel internationally (for measles and 
mumps) 
•  people who received inactivated (killed) measles 
vaccine or measles vaccine of unknown type during 
1963–1967 should be revaccinated with two doses 
of MMR vaccine.
•  people vaccinated before 1979 with either killed 
mumps vaccine or mumps vaccine of unknown type 
who are at high risk for mumps infection (e.g., 
persons who are working in a healthcare facility) 
should be considered for revaccination with 2 doses 
of MMR vaccine.
Why do healthcare personnel need vaccination 
or other evidence of immunity to measles, 
mumps, and rubella? 
People who work in medical facilities are at much 
higher risk for being exposed to disease than is the 
general population. Making sure that all employees 
are immune to these diseases protects both the 
employee and the patients with whom he or she  
may have contact. All people working in a healthcare 
facility in any capacity should have documentation 
of vaccination or evidence of immunity, including 
full- or part-time employees, medical or non-medical, 
paid or volunteer, students, and those with or without 
direct patient responsibilities.
Facilities should consider vaccinating with MMR 
vaccine healthcare personnel born before 1957 who 
lack laboratory evidence of measles, mumps, and 
rubella immunity or laboratory confirmation of  
previous disease. These facilities should vaccinate 
healthcare personnel with MMR during an outbreak 
of any of the diseases, regardless of birth year. 
Who recommends this vaccine? 
The Centers for Disease Control and Prevention 
(CDC), the American Academy of Pediatrics (AAP), 
the American Academy of Family Physicians (AAFP), 
the American College of Obstetricians and Gyne-
cologists, and the American College of Physicians 
(ACP) have all recommended this vaccine. 
How safe is this vaccine? 
Hundreds of millions of doses of measles, mumps, 
and rubella vaccine prepared either as separate  
vaccines or as the combined MMR have been given 
in the United States, and its safety record is excellent. 
What side effects have been reported with this 
vaccine? 
Fever is the most common side effect, occurring in 
5%–15% of vaccine recipients. About 5% of people 
develop a mild rash. When they occur, fever and  
rash usually appear 7–12 days after vaccination. 
About 25% of adult women receiving MMR vaccine 
develop temporary joint pain, a symptom related  
to the rubella component of the combined vaccine. 
Joint pain only occurs in women who are not immune 
to rubella at the time of vaccination. MMR vaccine 
may cause thrombocytopenia (low platelet count)  
at the rate of about 1 case per 30,000–40,000 vacci-
nated people. Cases are almost always temporary 
and not life-threatening. More severe reactions, 
including allergic reactions, are rare. Other severe 
problems (e.g., deafness, permanent brain damage) 
occur so rarely that experts cannot be sure whether 
they are caused by the vaccine or not. 
If a child develops a rash after getting the MMR  
vaccine, is he contagious? 
Transmission of the vaccine viruses does not occur 
from a vaccinated person, including those who 
develop a rash. No special precautions (e.g., exclusion 
from school or work) need be taken. 
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Who should NOT receive MMR vaccine? 
Anyone who had a severe allergic reaction (e.g., gen-
eralized hives, swelling of the lips, tongue, or throat, 
difficulty breathing) following the first dose of MMR 
should not receive a second dose. Anyone knowing 
they are allergic to an MMR component (e.g., gelatin, 
neomycin) should not receive this vaccine. 
As with all live virus vaccines, women known to be 
pregnant should not receive the MMR vaccine, and 
pregnancy should be avoided for four weeks following 
vaccination with MMR. Children and other household 
contacts of pregnant women should be vaccinated 
according to the recommended schedule. Women 
who are breast-feeding can be vaccinated. 
Severely immunocompromised people should not be 
given MMR vaccine. This includes people with con-
ditions such as congenital immunodeficiency, AIDS, 
leukemia, lymphoma, generalized malignancy, and 
those receiving treatment for cancer with drugs, radi-
ation, or large doses of corticosteroids. Household 
contacts of immunocompromised people should be 
vaccinated according to the recommended schedule. 
Although people with AIDS or HIV infection with 
signs of serious immunosuppression should not be 
given MMR, people with HIV infection who do not 
have laboratory evidence of severe immunosuppres-
sion can and should be vaccinated against measles.
Can individuals with egg allergy receive MMR  
vaccine? 
In the past it was believed that people who were 
allergic to eggs would be at risk of an allergic reaction 
from the vaccine because the vaccine is grown in 
tissue from chick embryos. However, recent studies 
have shown that this is not the case. MMR may be 
given to egg-allergic individuals without prior testing 
or use of special precautions.
Does the MMR vaccine cause autism? 
There is no scientific evidence that measles, MMR, 
or any other vaccine causes autism. The question 
about a possible link between MMR vaccine and 
autism has been extensively reviewed by independent 
groups of experts in the U.S. including the National 
Academy of Sciences’ Institute of Medicine. These 
reviews have concluded that there is no association 
between MMR vaccine and autism. 
For a summary of the issues on this topic, please 
read “Do Vaccines Cause Autism?” on the website  
of the Vaccine Education Center at Children’s Hospital 




Dr. Ari Brown has written a good piece for parents 
questioning the safety of vaccines. To access “Clear 
Answers & Smart Advice about Your Baby’s Shots,” 
go to: www.immunize.org/catg.d/p2068.pdf.
For more information, visit CDC’s web page about 
vaccines and autism at www.cdc.gov/vaccinesafety/
concerns/autism/index.html 
Can the live virus in the vaccine cause measles, 
mumps, and/or rubella? 
Because the measles, mumps, and rubella viruses  
in the MMR vaccine are weak versions of the disease 
viruses, they may cause a very mild case of the disease 
they were designed to prevent; however, it is usually 
much milder than the natural disease and is referred 
to as an adverse reaction to the vaccine. 
What if a pregnant woman inadvertently got the 
MMR vaccine? 
Women are advised not to receive any live virus  
vaccine during pregnancy as a safety precaution 
based on the theoretical possibility of a live vaccine 
causing disease (e.g., rubella virus leading to  
congenital rubella syndrome [CRS]). 
Because a number of women have inadvertently 
received this vaccine while pregnant or soon before 
conception, the Centers for Disease Control and  
Prevention has collected data about the outcomes  
of their births. From 1971–1989, no evidence of  
CRS occurred in the 324 infants born to 321 women 
who received rubella vaccine while pregnant and 
continued pregnancy to term. As any risk to the 
fetus from rubella vaccine appears to be extremely 
low or zero, individual counseling of women in this 
situation is recommended, rather than routine  
termination of pregnancy.
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